MBCL-46. TREATMENT OF RECURRENT WINGLESS-ACTIVATED MEDULLOBLASTOMA (Wnt-MB) INCORPORATING MARROW-ABLATIVE THIOTEPA AND CARBOPLATIN CHEMOTHERAPY (HDCx) AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL RESCUE (AuHPCR): A DUAL REPORT

Authors: Micah K Harris, Zachary N Funk, Daniel R Boué, Christopher R Pierson, Jeremy Jones, Jeffrey Leonard, Rolla Abu-Arja, Jeffrey Auletta, Diana S Osorio, Margaret Shatara, Stephan R Paul, Jonathan L Finlay, Mohamed S AbdelBaki

Published: 2020-12-04

DOI: 10.1093/neuonc/noaa222.517

Source: Full article

MBCL-46. TREATMENT OF RECURRENT WINGLESS-ACTIVATED MEDULLOBLASTOMA (Wnt-MB) INCORPORATING MARROW-ABLATIVE THIOTEPA AND CARBOPLATIN CHEMOTHERAPY (HDCx) AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL RESCUE (AuHPCR): A DUAL REPORT

Abstract